Stock & Company Details
Gyre Therapeutics Inc $GYRE
Price:
46,691,331
111M
$735M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
-14.99
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
GYRE technical indicators
Latest Gyre Therapeutics Inc (GYRE) technical indicators as of 2026-06-30: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
56.81 5.1%
MACD:
-0.02 66.1%
SMA 50:
$6.65 0.5%
SMA 200:
$7.44 0.1%
EMA 20:
$6.25 0.6%
Bollinger Bands:
6.61 / 5.60
Stochastic:
72.26 17.7%
ADX 14:
23.26 2.8%
ATR 14:
0.33 2.0%
CCI 20:
155.09 43.3%
OBV:
3.01M 2.1%
ROC 12:
8.75% 4.1%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options. we used a scientific approach focused on protease-based therapeutic candidates to build a clinical-stage biopharmaceutical company whose current mission is to develop valuable therapies for patients with hemophilia. learn more about our hemophilia program. a protease is an enzyme that cleaves target proteins. learn more about proteases.
Finance Bot
Ask your questions
Start by typing a question below.
